Breaking the mold: Overcoming resistance to immune checkpoint inhibitors

被引：4

作者：

Zhao, Menglu ^{[1
]}

Yan, Chun-Yan ^{[1
]}

Wei, Ya-Nan ^{[1
]}

Zhao, Xi-He ^{[1
]}

机构：

[1] China Med Univ, Shengjing Hosp, Dept Clin Oncol, Shenyang 110022, Peoples R China

来源：

ANTIVIRAL RESEARCH | 2023年 / 219卷

基金：

中国国家自然科学基金;

关键词：

PD-L1; Drug resistance; Bispecific antibody; Antibody drug conjugate (ADC); TUMOR MUTATIONAL BURDEN; T-CELLS; ANTITUMOR IMMUNITY; CANCER; IMMUNOTHERAPY; BLOCKADE; EFFICACY; RECEPTOR; PD-L1; EXPRESSION;

D O I：

10.1016/j.antiviral.2023.105720

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Immune checkpoint blockade-based therapies are effective against a sorts of cancers. However, drug resistance is a problem that cannot be ignored. This review intends to elucidate the mechanisms underlying drug tolerance induced by PD-1/PD-L1 inhibitors, as well as to outline proposed mechanism-based combination therapies and small molecule drugs that target intrinsic immunity and immune checkpoints. According to the differences of patients and types of cancer, the optimization of individualized combination therapy will help to enhance PD-1/ PD-L1-mediated immunoregulation, reduce chemotherapy resistance, and provide new ideas for chemotherapyresistant cancer.

引用

页数：11

共 128 条

[31] Combining epigenetic and immune therapy to overcome cancer resistance [J].

Gomez, Stephanie ;

Tabernacki, Tomasz ;

Kobyra, Julie ;

Roberts, Paige ;

Chiappinelli, Katherine B. .

SEMINARS IN CANCER BIOLOGY, 2020, 65 :99-113

[32] Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy [J].

Gong, Ying ;

Klein Wolterink, Roel G. J. ;

Wang, Jianxiang ;

Bos, Gerard M. J. ;

Germeraad, Wilfred T. V. .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)

[33] Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers [J].

Goodman, Aaron M. ;

Kato, Shumei ;

Bazhenova, Lyudmila ;

Patel, Sandip P. ;

Frampton, Garrett M. ;

Miller, Vincent ;

Stephens, Philip J. ;

Daniels, Gregory A. ;

Kurzrock, Razelle .

MOLECULAR CANCER THERAPEUTICS, 2017, 16 (11) :2598-2608

[34] DGKζ exerts greater control than DGKα over CD8+ T cell activity and tumor inhibition [J].

Gu, Junchen ;

Wang, Cindy ;

Cao, Carolyn ;

Huang, Jinwen ;

Holzhauer, Sandra ;

Desilva, Heshani ;

Wesley, Erin M. ;

Evans, Douglas B. ;

Benci, Joseph ;

Wichroski, Michael ;

Wee, Susan ;

Riese, Matthew J. .

ONCOIMMUNOLOGY, 2021, 10 (01)

[35] Sex difference in the expression of PD-1 of non-small cell lung cancer [J].

Gu, Yong ;

Tang, Ying Y. ;

Wan, Jian X. ;

Zou, Jian Y. ;

Lu, Chuan G. ;

Zhu, Hao S. ;

Sheng, Si Y. ;

Wang, Yan F. ;

Liu, Hai Ch. ;

Yang, Jia ;

Hong, Hai .

FRONTIERS IN IMMUNOLOGY, 2022, 13

[36] Cancer Immunoediting in the Era of Immuno-oncology [J].

Gubin, Matthew M. ;

Vesely, Matthew D. .

CLINICAL CANCER RESEARCH, 2022, 28 (18) :3917-3928

[37] M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages [J].

Gunassekaran, Gowri Rangaswamy ;

Vadevoo, Sri Murugan Poongkavithai ;

Baek, Moon-Chang ;

Lee, Byungheon .

BIOMATERIALS, 2021, 278

[38] Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors [J].

Hellmann, Matthew D. ;

Bivi, Nicoletta ;

Calderon, Boris ;

Shimizu, Toshio ;

Delafontaine, Brant ;

Liu, Zhuqing Tina ;

Szpurka, Anna M. ;

Copeland, Victoria ;

Hodi, F. Stephen ;

Rottey, Sylvie ;

Aftimos, Philippe ;

Piao, Yongzhe ;

Gandhi, Leena ;

Galvao, Violeta Regnier ;

Leow, Ching Ching ;

Doi, Toshihiko .

CLINICAL CANCER RESEARCH, 2021, 27 (10) :2773-2781

[39] The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function [J].

Hernandez, Sairy ;

Qing, Jing ;

Thibodeau, Rebecca Hong ;

Du, Xiangnan ;

Park, Summer ;

Lee, Hyang-Mi ;

Xu, Min ;

Oh, Soyoung ;

Navarro, Armando ;

Roose-Girma, Meron ;

Newman, Robert J. ;

Warming, Soren ;

Nannini, Michelle ;

Sampath, Deepak ;

Kim, Jeong M. ;

Grogan, Jane L. ;

Mellman, Ira .

CELL REPORTS, 2018, 25 (01) :80-94

[40] Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance [J].

Horn, Susanne ;

Leonardelli, Sonia ;

Sucker, Antje ;

Schadendorf, Dirk ;

Griewank, Klaus G. ;

Paschen, Annette .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (06) :677-681

← 1 2 3 4 5 6 7 8 9 10 →